225 Phase I–II study of high dose epidoxorubicin (EPI) plus cisplatin (DDP) in IIIb or IV non-small cell lung cancer (NSCLC): Searching the optimal DDP dosage

✍ Scribed by Quantin, X.; Oliver, P.; Rivière, A.; Khial, F.; Madelaine, J.; Pujol, J.L.

• Book ID: 122006099
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 288 KB
• Volume: 18
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(97)89607-9